Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity

Overview

Journal Vaccines (Basel)

Date 2022 Jun 24

PMID 35746489

Authors

Christina Bahrs

Nicole Harrison

Affiliations

Soon will be listed here.

Abstract

During the last few years, we have experienced a shift in how we evaluate the effectiveness of vaccines [...].

Citing Articles

Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients.

Bermejo-Gomez A, Tarancon-Diez L, Lazaro-Martin B, Santiago-Garcia B, Gil Villanueva N, Alonso R Heliyon. 2025; 11(1):e41584.

PMID: 39866443 PMC: 11758410. DOI: 10.1016/j.heliyon.2024.e41584.

Prophylactic and therapeutic vaccine development: advancements and challenges.

Weerarathna I, Doelakeh E, Kiwanuka L, Kumar P, Arora S Mol Biomed. 2024; 5(1):57.

PMID: 39527305 PMC: 11554974. DOI: 10.1186/s43556-024-00222-x.

COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.

Canha I, Silva M, Azevedo Silva M, Costa M, Saraiva R, Ruge A GE Port J Gastroenterol. 2024; 31(5):325-337.

PMID: 39360169 PMC: 11444661. DOI: 10.1159/000534740.

Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.

Hendy D, Lifshits L, Batty C, Carlock M, Ross T, Mousa J Mol Pharm. 2023; 20(9):4687-4697.

PMID: 37603310 PMC: 11654055. DOI: 10.1021/acs.molpharmaceut.3c00424.

References

Ruthrich M, Giesen N, Mellinghoff S, Rieger C, von Lilienfeld-Toal M . Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences. Vaccines (Basel). 2022; 10(2). PMC: 8875094. DOI: 10.3390/vaccines10020182. View

Arora S, Kipp G, Bhanot N, Sureshkumar K . Vaccinations in kidney transplant recipients: Clearing the muddy waters. World J Transplant. 2019; 9(1):1-13. PMC: 6347668. DOI: 10.5500/wjt.v9.i1.1. View

Tarke A, Sidney J, Methot N, Yu E, Zhang Y, Dan J . Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals. Cell Rep Med. 2021; 2(7):100355. PMC: 8249675. DOI: 10.1016/j.xcrm.2021.100355. View

Speich B, Chammartin F, Abela I, Amico P, Stoeckle M, Eichenberger A . Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial. Clin Infect Dis. 2022; 75(1):e585-e593. PMC: 8903480. DOI: 10.1093/cid/ciac169. View

Malipiero G, Moratto A, Infantino M, DAgaro P, Piscianz E, Manfredi M . Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease. Immunol Res. 2021; 69(6):576-583. PMC: 8379062. DOI: 10.1007/s12026-021-09226-z. View

Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F . Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2022; 2(12):1305-1320. DOI: 10.1038/s43018-021-00274-w. View

Gackler A, Mulling N, Volk K, Wilde B, Eisenberger U, Rohn H . Establishment of an ELISpot Assay to Detect Cellular Immunity against in Vaccinated Kidney Transplant Recipients. Vaccines (Basel). 2021; 9(12). PMC: 8706129. DOI: 10.3390/vaccines9121438. View

Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W . Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013; 19(10):1305-12. DOI: 10.1038/nm.3350. View

Nazi I, Kelton J, Larche M, Snider D, Heddle N, Crowther M . The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013; 122(11):1946-53. PMC: 3773242. DOI: 10.1182/blood-2013-04-494096. View

10.

Geers D, Shamier M, Bogers S, Den Hartog G, Gommers L, Nieuwkoop N . SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol. 2021; 6(59). PMC: 9268159. DOI: 10.1126/sciimmunol.abj1750. View

11.

Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Al Zahrani M . COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021; 35(10):2885-2894. PMC: 8171362. DOI: 10.1038/s41375-021-01302-5. View

12.

Mariotti J, Spina F, Carniti C, Anselmi G, Lucini D, Vendramin A . Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies. Eur J Haematol. 2012; 89(2):111-9. DOI: 10.1111/j.1600-0609.2012.01793.x. View

13.

Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A . Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant. 2009; 44(8):457-62. DOI: 10.1038/bmt.2009.255. View

14.

Harrison N, Grabmeier-Pfistershammer K, Graf A, Schwarzinger I, Aberle J, Stiasny K . Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients. NPJ Vaccines. 2020; 5(1):67. PMC: 7381595. DOI: 10.1038/s41541-020-00215-1. View

15.

Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C . Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019; 19(6):e200-e212. DOI: 10.1016/S1473-3099(18)30600-5. View

16.

Harrison N, Grabmeier-Pfistershammer K, Graf A, Trapin D, Tauber P, Aberle J . Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination. Vaccines (Basel). 2021; 9(8). PMC: 8402406. DOI: 10.3390/vaccines9080908. View

17.

Kratzer B, Trapin D, Gattinger P, Oberhofer T, Sehgal A, Waidhofer-Sollner P . Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma. Vaccines (Basel). 2022; 10(3). PMC: 8949333. DOI: 10.3390/vaccines10030374. View

18.

Lindemann M, Klisanin V, Thummler L, Fisenkci N, Tsachakis-Muck N, Ditschkowski M . Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients. Vaccines (Basel). 2021; 9(10). PMC: 8537291. DOI: 10.3390/vaccines9101075. View